The legislation allows terminally ill patients access to experimental drugs.
President Trump is expected to sign the bill that has divided advocates.
Advocates for the bill say it will make it easier for patients to get access to experimental drugs that have completed the first phase of clinical trials and are in the midst of...Arizona News
At issue is how dying people can get access to unapproved medicines.
The FDA permitted two people infected with the Ebola virus to be administered ZMapp, even though the drug had not been approved for human testing. The Goldwater Institute goes to court Tuesday, Oct. 10, trying to force the FDA to reveal details on how dying people...